SINGULAIR PAEDIATRIC 4MG ORAL GRANULES 14 SACHETS

SINGULAIR PAEDIATRIC 4MG ORAL GRANULES 14 SACHETS

سعر SINGULAIR PAEDIATRIC 4MG ORAL GRANULES 14 SACHETS

98.00 جنية

الشركة المنتجة لـ SINGULAIR PAEDIATRIC 4MG ORAL GRANULES 14 SACHETS

MERCK SHARP & DOHME > GLOBAL NAPI PHARMACEUTICALS

المادة الفعالة SINGULAIR PAEDIATRIC 4MG ORAL GRANULES 14 SACHETS

MONTELUKAST

معلومات عن SINGULAIR PAEDIATRIC 4MG ORAL GRANULES 14 SACHETS

About Montelukast Leukotriene(CysLT1) Receptor Antagonist Antiinflammatory antiasthma. Mechanism of Action of Montelukast Montelukast is competitively and selectively antagonizes CysLT1 receptor (leukotrienes receptor) mediated Bronchoconstriction.Montelukast inhibits physiologic actions of LTD 4 at the CysLT1 receptor without any agonist activity. Indications for Montelukast Asthma. Interactions for Montelukast Barbiturates & Primidone: Plasma concentration of montelukast is reduced by phenobarbital.

الدومين dw2.org ومحتوى الموقع للبيع بسعر 4900 دولار.

للتواصل عبر هذا الايميل [email protected]